|
Volumn 66, Issue 1, 2002, Pages 42-49
|
Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENALIN;
ALPHA 2 ADRENERGIC RECEPTOR;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
FATTY ACID;
GLUCAGON;
GLUCOSE;
HYDROCORTISONE;
INSULIN;
MEDETOMIDINE;
NEUROHORMONE;
NORADRENALIN;
SODIUM CHLORIDE;
XYLAZINE;
ADRENALIN BLOOD LEVEL;
ADRENALIN RELEASE;
ARTICLE;
BLOOD SAMPLING;
CENTRAL VENOUS CATHETER;
CONTROLLED STUDY;
DOG;
DOSE TIME EFFECT RELATION;
DRUG MECHANISM;
DRUG POTENCY;
FATTY ACID BLOOD LEVEL;
FEMALE;
GLUCAGON BLOOD LEVEL;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
HORMONE BLOOD LEVEL;
HYDROCORTISONE BLOOD LEVEL;
HYPERGLYCEMIA;
INHIBITION KINETICS;
INSULIN BLOOD LEVEL;
INSULIN RELEASE;
LIPOLYSIS;
MALE;
METABOLIC PARAMETERS;
NONHUMAN;
NORADRENALIN BLOOD LEVEL;
NORADRENALIN RELEASE;
ADRENERGIC ALPHA-AGONISTS;
ANIMALS;
BLOOD GLUCOSE;
CATECHOLAMINES;
DOGS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FATTY ACIDS, NONESTERIFIED;
FEMALE;
GLUCAGON;
HYDROCORTISONE;
INJECTIONS, INTRAMUSCULAR;
INSULIN;
MALE;
MEDETOMIDINE;
RANDOM ALLOCATION;
TIME FACTORS;
XYLAZINE;
CANIS FAMILIARIS;
|
EID: 0036182557
PISSN: 08309000
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (82)
|
References (39)
|